Pharmafile Logo
Pharmafocus logo
Advanced Search

Italy plans cancer drug price cut

July 7, 2010
Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing

Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …

News
Biogen_Scangos

George Scangos to head up Biogen

July 7, 2010
Research and Development Biogen, appointment, research and development

Biogen Idec has appointed George Scangos chief executive officer, with effect from 15 July. Scangos will join the company from …

Appointment

4Sight launches conference division

July 7, 2010
Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing

UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …

News

European scrutiny of pharma patent deals to continue

July 6, 2010
Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …

News

Bind Biosciences appoints Dr Ed Schnipper

July 6, 2010
Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development

US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …

Appointment
Herceptin packs

NICE set to block Herceptin for gastric cancer

July 6, 2010
Sales and Marketing Herceptin, NICE, Roche, gastric cancer

NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …

News

NHS slow to tackle health inequalities

July 6, 2010
NHS, NHS targets

The NHS has not moved quickly enough to tackle inequalities in life expectancy in areas with the worst health and …

News

More woe for Genzyme as shipping delays continue

July 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …

News

Pharma manufacturing news in brief

July 6, 2010
Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar

New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …

News
Roche BioOncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part two)

July 5, 2010
Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …

Feature

AstraZeneca collaborates on compound library

July 5, 2010
Research and Development AstraZeneca, MRC

AstraZeneca and the UK’s Medical Research Council are to share access to their compounds to improve their efforts to find …

News
Margot James

Margot James: Tories to ‘nudge’ change in NHS

July 5, 2010
Medical Communications, Sales and Marketing NHS, government, pm society

Speaking to the industry for the first time since being elected as Conservative MP for Stourbridge at the recent General …

News

Lilly set to acquire Alnara Pharmaceuticals

July 5, 2010
Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly

Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …

News

Ovarian cancer trial boost for Avastin

July 5, 2010
Research and Development Roche, avastin, ovarian cancer

Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …

News
GSK workers protest

Aptuit deal saves GSK’s R&D unit in Verona

July 5, 2010
Manufacturing and Production, Research and Development Aptuit, GlaxoSmithKline, Italy

GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …

News
Duncan-Learmouth

Duncan Learmouth to lead new GSK unit

July 5, 2010
Sales and Marketing GlaxoSmithKline, appointment, em, market access, sales and marketing

GlaxoSmithKline has created a new business group dedicated to improving access to medicines in the world’s least developed countries. GSK’s …

Appointment

European Court upholds AZ Losec judgement

July 2, 2010
Sales and Marketing AstraZeneca, Losec, generics

The General Court of the EU has upheld the European Commission’s 2005 decision that AstraZeneca were guilty of blocking cheaper …

News

NICE thumbs up for Roche arthritis drug

July 2, 2010
Sales and Marketing NICE, RoActemra, Roche

NICE has given preliminary approval to Roche’s RoActemra as an additional option for the treatment of moderate to severe rheumatoid …

News
ABPI

New ABPI Code for 2011

July 2, 2010
Medical Communications, Sales and Marketing ABPI, Code of Practice, nhs partnerships

New guidance on the way pharma companies should approach marketing themselves to doctors are among the key changes in a …

News
Pfizer Oncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part one)

July 2, 2010
Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, digital pharma, ipad, iphone

Most sectors of business have been eagerly eyeing, and responding to, the potential of Apple’s iPhone, and this year’s iPad …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026